Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02638194 · ClinicalTrials.gov registry record · NA
Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02638194: Completed NA study, sponsored by NYU Langone Health.
NCT02638194 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02638194, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The primary purpose of this study is to examine the health effects of mainstream and secondhand hookah (i.e. water pipe) smoke on pulmonary and cardiovascular functions as well as serum levels of inflammatory biomarkers. Investigators would like to demonstrate that inhalation of both mainstream and secondhand smoke generated by hookah produces adverse pulmonary and cardiovascular effects and alterations in serum levels of inflammatory biomarkers.
Interventions
- OTHER Active smoking of Tobacco Hookah for 2 hours
- OTHER Exposure to tobacco hookah second hand smoke
- OTHER Visit a win bar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT02638194 record still lists
NCT02638194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Active smoking of Tobacco Hookah for 2 hours is the first listed.
NCT02638194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02638194 about?
NCT02638194 is a clinical study titled "Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars". The primary purpose of this study is to examine the health effects of mainstream and secondhand hookah (i.e. water pipe) smoke on pulmonary and cardiovascular functions as well as serum levels of inflammatory biomarkers. Investigators would like to demonstrate that inhalation of both mainstream and ...
What is the current status of trial NCT02638194?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02638194?
The interventions under investigation include: Active smoking of Tobacco Hookah for 2 hours (OTHER), Exposure to tobacco hookah second hand smoke (OTHER), Visit a win bar (OTHER).
Who is sponsoring clinical trial NCT02638194?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02638194's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia